Mersen (MRN) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
3 Feb, 2026Executive summary
Achieved record 2024 sales of €1,244 million, with a 10% CAGR since 2020, driven by North America and strong transportation, wind, and process industry demand, offsetting weaker solar and semiconductor markets.
Three US acquisitions completed, expanding the US footprint and product offering, with integration progressing smoothly and adding ~€60 million in annual sales.
Adaptation and cost optimization plans implemented, impacting inventories and EBITDA, with significant non-recurring expenses and €17 million in gains for 2024.
Strong operating cash flow before capital expenditure, exceeding 2023 levels, supporting a proposed €0.90 per share dividend (37% payout ratio).
Solid financial structure with net debt at €370 million and leverage at 1.8x, well within policy limits.
Financial highlights
EBITDA before non-recurring items reached €205.5 million (16.5% margin), up from €202.7 million in 2023.
Net income for 2024 was €59 million, down from €81.6 million in 2023, impacted by €23 million in non-recurring expenses and higher financial costs.
Cash generation and operating cash flow before capex increased, supported by inventory reduction and advance payments on SiC contracts.
Dividend proposed at €0.90 per share, representing a 37% payout ratio.
ROCE declined to 10.8% from 13.0% in 2023, reflecting a major investment cycle.
Outlook and guidance
2025 organic sales growth expected between -5% and 0%, with EBITDA margin guidance of 16–16.5% and operating margin of 9–9.5%.
CapEx for 2025 targeted at €160–170 million, with a reduction in investment levels planned for subsequent years.
Medium-term (2029) targets reaffirmed: sales of ~€1.7 billion, 12% operating margin, 19% EBITDA margin, and 13% ROCE.
Latest events from Mersen
- 2025 delivered resilient margins and positive cash flow; growth and stable margins expected in 2026.MRN
H2 20258 Jul 2026 - Sales fell 4.3% organically in Q3, prompting lower guidance and reduced capital expenditure.MRN
Q3 2025 TU8 Jul 2026 - Growth targets delayed to 2029, but strong strategy and investments support long-term ambitions.MRN
CMD 20248 Jul 2026 - Q1 2026 organic sales grew 3.1% to €296m, led by Electrical Power and North America.MRN
Q1 2026 TU28 Apr 2026 - Record sales and 10.5% margin, led by transport and North America; solar, SiC to slow.MRN
Q4 2024 TU3 Feb 2026 - 2025 sales fell 3.2% organically, but margins and capex guidance were maintained.MRN
Q4 2025 TU3 Feb 2026 - Record H1 sales and margin growth, with US expansion and 2024 guidance confirmed.MRN
H1 20242 Feb 2026 - Q3 growth slowed to 1.2% amid solar and semiconductor weakness; 2024 guidance revised down.MRN
Q3 2024 TU19 Jan 2026 - Q1 2025 sales fell 2.5% to €305m as solar and SiC slumped, but wind and rail grew strongly.MRN
Q1 2025 TU23 Dec 2025